Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.9 CAD | +1.72% | 0.00% | +2.43% |
Mar. 11 | National Bank Revises 2024, 2025 Estimates for Dexterra Group Following Q4 Results | MT |
Mar. 11 | Dexterra Upgraded to Outperform at Raymond James | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.24 for the current year.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.41 for the 2024 fiscal year.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Hotels, Motels & Cruise Lines
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.43% | 276M | B- | ||
+6.80% | 69.42B | C+ | ||
+11.00% | 50.54B | B | ||
+13.31% | 16.25B | A- | ||
+16.03% | 15.31B | C+ | ||
+22.20% | 11.17B | A- | ||
+29.70% | 9.7B | A- | ||
+11.86% | 5.05B | A | ||
+10.35% | 4.64B | C- | ||
+23.03% | 3.79B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DXT Stock
- Ratings Dexterra Group Inc.